Tenet Healthcare Corp. (THC) intrinsic value & 10-year financials

Tenet Healthcare Corp. (THC) has a Graham intrinsic value of $514.51 per share. At $267.25 on Oct 17, 2026, the stock trades 48% below that value. Over the last 10 fiscal years revenue grew 0.1% a year to $21.3B, with an average return on invested capital of 13.3%.

Graham intrinsic value
$514.51
Share price (Oct 17, 2026)
$267.25
Price vs Graham value
48% below
Market cap
$24.3B
Revenue (FY2025)
$21.3B
Revenue growth (10-yr CAGR)
0.1%
ROIC (10-yr avg)
13.3%
Free cash flow (FY2025)
$2.5B

THC 10-year financial history

Fiscal year Revenue Net income EPS (diluted) Free cash flow Operating margin ROIC
FY2025 $21.3B $2.4B $15.49 $2.5B 16.5% 20.4%
FY2024 $20.7B $4.1B $32.70 $1.1B 28.8% 30.8%
FY2023 $20.5B $1.3B $5.71 $1.6B 12.2% 13.1%
FY2022 $19.2B $1.0B $3.79 $321.0M 12.2% 11.6%
FY2021 $19.5B $1.5B $8.42 $910.0M 14.7% 16.1%
FY2020 $17.6B $768.0M $3.75 $2.9B 11.3% 14.3%
FY2019 $18.5B $154.0M -$2.24 $563.0M 8.2% 5.3%
FY2018 $18.3B $466.0M $1.07 $432.0M 9.0% 8.3%
FY2017 $20.6B -$320.0M -$7.00 $493.0M 5.4% 7.5%
FY2016 $21.1B $176.0M -$1.93 -$317.0M 5.8% 5.8%

Source: annual 10-K filings on SEC EDGAR. Figures in USD.

Executive summary

TENET HEALTHCARE CORP has demonstrated mature, steady growth, with revenue compounding at 0.1% annually over the past decade.

TENET HEALTHCARE CORP returns on capital have been average, hovering around 13.3% ROIC over the decade.

TENET HEALTHCARE CORP has not shown aggressive share repurchases (>10% retirement) or a major balance-sheet leverage increase (>50% net debt growth) over the 10-year window.

Benjamin Graham lens

Under Benjamin Graham's formula using SEC EDGAR fundamentals, TENET HEALTHCARE CORP is modeled at 15.0% normalized earnings growth with a 5.1% bond-yield adjustment. The resulting Graham intrinsic value estimate is $514.51 per share.

THC stock: frequently asked questions

What is the intrinsic value of Tenet Healthcare Corp. (THC) stock?

Using Benjamin Graham's revised formula, V = EPS × (8.5 + 2g) × 4.4 / Y, with reported diluted earnings per share, a 15.0% normalized growth rate (capped at 15%) and a 5.1% AAA corporate bond yield, THC's intrinsic value is about $514.51 per share.

Is THC stock undervalued?

At $267.25 (close on Oct 17, 2026), THC trades 48% below its Graham value of $514.51. On Graham's terms that leaves a margin of safety. A formula is a starting point for research, not a recommendation.

How fast has Tenet Healthcare Corp. grown?

Revenue went from $21.1B in fiscal 2016 to $21.3B in fiscal 2025, a compound annual growth rate of 0.1%. Net income was $2.4B in fiscal 2025.

Does Tenet Healthcare Corp. generate free cash flow?

Tenet Healthcare Corp. generated $2.5B of free cash flow (operating cash flow minus capital expenditures) in fiscal 2025. Free cash flow was positive in 9 of the last 10 reported years.

What is THC's return on invested capital?

Average ROIC over the last 10 fiscal years was 13.3%, and average return on equity was -39.2%. Sustained ROIC above about 15% usually points to a durable competitive advantage.

Where does this THC data come from?

From Tenet Healthcare Corp.'s annual 10-K filings on SEC EDGAR, most recently filed Jul 29, 2026. Prices are end-of-day snapshots; valuations are formula outputs, not investment advice.

Similar general medical & surgical hospitals stocks